Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.605 USD | -2.13% | -10.00% | -31.36% |
Mar. 27 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 35
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Glycomimetic Compounds
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -86.67% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -86.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Edwin Rock
CTO | Chief Tech/Sci/R&D Officer | 63 | 22-09-05 |
Chinmaya Rath
PRN | Corporate Officer/Principal | 48 | - |
Bruce Johnson
PRN | Corporate Officer/Principal | 56 | 22-02-22 |
General Counsel | - | 19-04-28 | |
Comptroller/Controller/Auditor | 53 | 13-12-31 | |
Lisa V. DeLuca
LAW | General Counsel | - | 21-11-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 60 | 18-11-27 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Scott Koenig
BRD | Director/Board Member | 71 | 17-03-12 |
Timothy Pearson
CHM | Chairman | 56 | 14-03-30 |
Mark Goldberg
BRD | Director/Board Member | 69 | 14-07-09 |
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,450,385 | 62,465,183 ( 96.92 %) | 0 | 96.92 % |
Company contact information
GlycoMimetics, Inc.
9708 Medical Center Drive
20850, Rockville
+240 243 1201
http://www.glycomimetics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.36% | 106M | |
-2.54% | 103B | |
+1.74% | 95.28B | |
+1.46% | 22.15B | |
-15.61% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.69% | 16.05B | |
+5.58% | 13.68B | |
+34.33% | 12.17B |
- Stock Market
- Equities
- GLYC Stock
- Company GlycoMimetics, Inc.